Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.

CONCLUSION: This study suggests superior performance of CA4P in metastatic over primary liver cancers, which could guide future clinical applications of vascular-disrupting-agents.​.
PMID: 29991876 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - July 7, 2018 Category: Gastroenterology Authors: Liu YW, De Keyzer F, Feng YB, Chen F, Song SL, Swinnen J, Bormans G, Oyen R, Huang G, Ni YC Tags: World J Gastroenterol Source Type: research